Completed
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
NCT01309932
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
- Locations
-
- Mayo Clinic Hospital Phoenix, Arizona, United States
- Desert Medical Group Inc. Palm Springs, California, United States
- University Of Colorado Denver And Hospital Aurora, Colorado, United States
- Yale University School Of Medicine New Haven, Connecticut, United States